Loading...
Hormonal therapies in young breast cancer patients: when, what and for how long?
Breast cancer in young women (<40 years) is a rare and complex clinical and psychosocial condition, which deserves multidisciplinary and personalized approaches. In young women with hormone-receptor positive disease, 5 years of adjuvant tamoxifen, with or without ovarian suppression/ablation, is...
Saved in:
Main Authors: | , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Pioneer Bioscience Publishing Company
2013
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3695542/ https://ncbi.nlm.nih.gov/pubmed/23819026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2013.05.25 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|